Slovakia wants to declassify CBD from the list of psychotropic substances
Slovakia announced yesterday that the List of Narcotics and Psychotropic Substances will be amended nationwide, including, in particular, the elimination of the cannabidiol (CBD) on this list. Two new psychoactive substances, 3-CMC and 4-CMC, will now be included in the first group of psychotropic substances. According to statements from the Ministry of the Interior, ten other psychoactive substances are also expected to be reclassified and included in the list of psychotropic substances in the first group, although we do not yet know which ones.
This decision to remove cannabidiol from the list of psychotropic substances was justified by the World Health Organization’s (WHO) amendment, which classifies it as harmless and non-addictive. The WHO director had in fact recommended last January the non-scheduling of the cannabidiol molecule, an essential component of cannabis; the removal of cannabis from Schedule IV of the Single Convention on Narcotic Drugs; and the inclusion of cannabinoid-based preparations in Schedule III. Furthermore, this substance does not appear on any United Nations list or in any United Nations conventions.
In particular, this development should make it possible in the coming months to simplify international law governing the production and distribution of cannabis-derived health products. With this change in classification, cannabis remains a narcotic, but the conditions for its medical use will be somewhat eased.
According to lawmakers, the bill will help strengthen social protection and prevent addiction to narcotics and psychotropic substances. It will also help regulate the black market and exercise greater control over criminal activities related to drug trafficking. The Slovak law will take effect on January 1, 2020.
-
Business4 weeks ago
Cronos Completes the Acquisition of CanAdelaar for 57.5 million euros
-
Cannabis in Quebec3 weeks ago
Cannabis: What France Could Learn from Quebec, Eight Years After Legalization
-
Cannabis in New Zealand3 weeks ago
Chronic Pain: New Zealand Is Testing Cannabis to Improve Sleep
-
Cannabis in France3 weeks ago
Dr. Pascal Douek, a tireless advocate for medical cannabis in France, has died
-
Cannabis in France3 weeks ago
Medical cannabis: The Greens introduce two amendments to accelerate its widespread adoption
-
Cannabis in Spain4 weeks ago
Spain: Medical Cannabis Is Coming to About 50 Hospitals
-
Business4 weeks ago
British patients now have access to THCV-rich cannabis flowers
-
Cannabis in Canada3 weeks ago
A Canadian study reveals the pleasant psychotropic effects of high-dose CBD


You must be logged in to post a comment Login